(MENAFN- America News Hour) “The report on
GAS Pharyngitis Diagnostics Market
was recently published by SDKI, which includes the latest market trends, current and future opportunities along with the factors that are driving the growth of the market. This report further encompasses the records for the expansion of the market along with information on the investment opportunities that help the clients to take positive decisions on the parameters for gaining profitable revenues. Moreover, the report also contains identification and investigation of the market structure, in-depth qualitative analysis, restraints & challenges, growth drivers, emerging product trends & market opportunities and Porter's five forces.
Download Sample of This Strategic Report:
GAS Pharyngitis Diagnostics Market: Overview Pharyngitis is inflammation of the pharynx, which is in the back of the throat. It is most often referred to simply as sore throat. Numerous viral and bacterial agents can cause pharyngitis and GAS pharyngitis is one of the bacterial infections caused by specially group A streptococcus. The market for GAS pharyngitis diagnostic is likely to expand significantly, as the incidence of GAS pharyngitis rises, especially among adolescents According to Regents of the University of California, every year, more than
600 million
cases of pharyngitis are reported worldwide and group A streptococcus (gas) is responsible for more than
30%
of pharyngitis infection. Moreover, group A streptococcus (GAS) is the trigger for post-infectious immune-mediated rheumatic heart disease, which kills more than
300,000
people annually.
GAS Pharyngitis Diagnostics: Market Drivers Several companies, as a part of strategy, are investing a high proportion of their revenue in pipeline product development with an objective to generate tests with high efficacy, within a short period, along with research in first-in-type test candidates, which is driving the market. For instance, in 2023 , GenePOC Inc., received the U.S. FDA clearance for GenePOC Strep A assay. The GenePOC Strep A assay can provide results from up to eight samples as early as within 42 minutes for positive specimens and in approximately 70 minutes for negative specimens, without the need for culture confirmation. Moreover, incidence and prevalence of GAS pharyngitis infection are gradually increasing across the globe. For instance, according to the CDC, report 2023 , the incident rate of preventable invasive group A streptococcal disease increased from 5.8 per 100,000 in 2023 to 7.26 per 100,000 in 2033 . This is also rising the demand for GAS pharyngitis diagnostic.
GAS Pharyngitis Diagnostics: Market Segmentation Based on product, the global GAS pharyngitis diagnostics market has been divided into rapid test kit, culture test, and PCR-based test Based on end user, the global GAS pharyngitis diagnostics market has been classified into hospitals, physician clinics, and diagnostic laboratories Each segment of the GAS pharyngitis diagnostics market has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights The report (GAS pharyngitis diagnostics) provides current and future revenue (US$ Mn) for each of these segments from 2023-2033, considering 2023 as the base year. The compound annual growth rate (%CAGR) has been provided for each segment of GAS pharyngitis diagnostics market from 2023-2033 , along with market size estimations.
GAS Pharyngitis Diagnostics Market: Regional Overview In terms of region, the global GAS pharyngitis diagnostics market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions. North America is expected to dominate the GAS pharyngitis diagnostics market during the forecast period. The GAS pharyngitis diagnostics market in Asia Pacific is estimated to expand at a high CAGR during the forecast period. The current and future values in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2023-2033 , with their CAGRs for the period from 2023-2033 The study also offers a list of recommendations, highlights, and useful insights of the GAS pharyngitis diagnostics market which would help new companies willing to enter the GAS pharyngitis diagnostics market and existing companies to increase market shares, and help in the decision-making process
GAS Pharyngitis Diagnostics Market: Major Players
The report concludes with the company profiles section that includes key information about the major players in the global GAS pharyngitis diagnostics market Key players analyzed in this report are Quidel Corporation BD Abbott Laboratories bioMérieux SA Hoffmann-La Roche Ltd Beckman Coulter, Inc. (Danaher) Meridian Bioscience, Inc. DiaSorin S.p.A. Sekisui Diagnostics
Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
GAS Pharyngitis Diagnostics Market – Scope of the Report
The report on the global GAS pharyngitis diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2023-2033. The report provides the overall market revenue of the global GAS pharyngitis diagnostics market for the period of 2023-2033, with 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global GAS pharyngitis diagnostics market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global GAS pharyngitis diagnostics market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approach to study various phenomena in the global GAS pharyngitis diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global GAS pharyngitis diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global GAS pharyngitis diagnostics market.
The report delves into the competitive landscape of the global GAS pharyngitis diagnostics market. Key players operating in the global GAS pharyngitis diagnostics market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global GAS pharyngitis diagnostics market that have been profiled in this report.
Key Questions Answered in GAS Pharyngitis Diagnostics Market Report
What is the sales/revenue generated by each product type across all regions during the forecast period? What are the opportunities in the global GAS pharyngitis diagnostics market? What are the major drivers, restraints, opportunities, and threats in the market? Which region is likely to expand at the fastest CAGR during the forecast period? Which test kit types are expected to generate the highest revenue globally in 2023? Which segment is projected to expand at the highest CAGR during the forecast period? What was the market share or position of different companies operating in the global market in 2023?
GAS Pharyngitis Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global GAS pharyngitis diagnostics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, technological advancement in different kits, pricing of the test, user of the systems in the year 2023, and key mergers & acquisitions to combat in the market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.